BioAtla
VC Fund
San Diego, United States
BioAtla is a VC fund in San Diego focused on Medical and Big Data. BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform. BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated AntibodyOptimization (CIAO!) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow them to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment, even when the target is also found in normal tissue, not only improves safety but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BioAtla invests in
Stages BioAtla invests in
Countries BioAtla invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 1 (100%)
- Big Data 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chris Vasquez
CFO and Principal Financial Officer; Chief Accounting Officer, Controller, Corporate Secretary
|
CFO and Principal Financial Officer; Chief Accounting Officer, Controller, Corporate Secretary | Total investments: 0 | Find email | |
Eric Sievers
Chief Medical Officer
|
Chief Medical Officer | Total investments: 0 | Find email | |
Jay M. Short
Chairman, CEO and Cofounder
|
Chairman, CEO and Cofounder | Total investments: 0 | Find email | |
|
Richard A. Waldron
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Scott A. Smith
President & Board Member
|
President & Board Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Exuma Biotech
|
EXUMA Biotech is a clinical-stage biotechnology company discovering and developing Chimeric Antigen Receptor (CAR)-T cell products for solid tumors. They develop new tools for the patient’s immune system to fight various solid tumor malignancies, such as renal cell carcinoma, soft tissue sarcoma, gastric cancer, and others.It was founded in 2015and headquartered in Grand Cayman, Midland. | $37M / Series A / Feb 16, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does BioAtla invest in?
BioAtla invests primarily in Medical, Big Data and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Cayman Islands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BioAtla?
Public channels for BioAtla include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BioAtla?
The team at BioAtla includes Chris Vasquez (CFO and Principal Financial Officer; Chief Accounting Officer, Controller, Corporate Secretary), Eric Sievers (Chief Medical Officer) and Jay M. Short (Chairman, CEO and Cofounder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
